Cargando…
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma
BACKGROUND: Toll-like receptor 9 (TLR9) is a cellular DNA-receptor whose activation with cognate ligands triggers an immune reaction, with increased production of inflammatory cytokines. The aim of this study was to examine the expression of TLR9 in renal cell carcinoma (RCC), which is generally ren...
Autores principales: | Ronkainen, Hanna, Hirvikoski, Pasi, Kauppila, Saila, Vuopala, Katri S, Paavonen, Timo K, Selander, Katri S, Vaarala, Markku H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182949/ https://www.ncbi.nlm.nih.gov/pubmed/21929816 http://dx.doi.org/10.1186/1756-9966-30-84 |
Ejemplares similares
-
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer
por: VÄISÄNEN, MARJA-RIITTA, et al.
Publicado: (2013) -
Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2010) -
Evaluation of neuroendocrine markers in renal cell carcinoma
por: Ronkainen, Hanna, et al.
Publicado: (2010) -
Identification of androgen-regulated genes in human prostate
por: VAARALA, MARKKU H., et al.
Publicado: (2012) -
Toll-Like Receptors in Esophageal Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2014)